Disclosures for "Microburst Vagus Nerve Stimulation: Safety and Efficacy Outcomes")
-
Dr. Drees has nothing to disclose.
-
Dr. Brown has nothing to disclose.
-
The institution of Dr. McDermott has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Marinus Pharmaceuticals . Dr. McDermott has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK biosciences .
-
The institution of Dr. Kaye has received research support from NeuroPace. The institution of Dr. Kaye has received research support from LivaNova.
-
Dr. O'Dwyer has nothing to disclose.
-
Dr. Macken has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharma. Dr. Macken has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK LifeSciences. Dr. Macken has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova. Dr. Macken has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Hall Prangle Shonfeld. The institution of Dr. Macken has received research support from LivaNova.
-
Dr. Zafar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon Pharmaceuticals. Dr. Zafar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova . The institution of Dr. Zafar has received research support from UCB. The institution of Dr. Zafar has received research support from SK life. The institution of Dr. Zafar has received research support from Marinus. The institution of Dr. Zafar has received research support from LivaNova. The institution of Dr. Zafar has received research support from Biopharma. The institution of Dr. Zafar has received research support from Neurocrine. The institution of Dr. Zafar has received research support from Hartwell Foundation.
-
Dr. Tatum has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bioserenity. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Defense Law Firm on behalf of a patient with epilepsy with funds donated to the Epilepsy Foundation of America. The institution of Dr. Tatum has received research support from Esai. The institution of Dr. Tatum has received research support from Mayo Clinic. The institution of Dr. Tatum has received research support from Liva Nova. The institution of Dr. Tatum has received research support from Engage Pharmaceuticals. The institution of Dr. Tatum has received research support from Xenon. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care.
-
Dr. Jaisani has nothing to disclose.
-
Prof. Vonck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Livanova. Prof. Vonck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synergia Medical. Prof. Vonck has received personal compensation in the range of $0-$499 for serving as a Consultant for All Man Foundation. Prof. Vonck has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Livanova. Prof. Vonck has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. The institution of Prof. Vonck has received research support from FWO. The institution of Prof. Vonck has received research support from GSKE.
-
The institution of Dr. Afra has received research support from LivaNova and UCB. Dr. Afra has a non-compensated relationship as a board member (representing AAN) with CoA-NDT that is relevant to AAN interests or activities.
-
Dr. Newman has nothing to disclose.
-
Ryan Verner has received personal compensation for serving as an employee of LivaNova USA Inc. Ryan Verner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sella Therapies. Ryan Verner has stock in LivaNova PLC.
-
Ms. Keith has received personal compensation for serving as an employee of LivaNova USA, Inc.. Ms. Keith has stock in LivaNova USA, Inc..
-
Dr. Jiang has received personal compensation for serving as an employee of LivaNova Inc. Dr. Jiang has stock in LivaNova.
-
Dr. Benbadis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stratus. Dr. Benbadis has received personal compensation in the range of $0-$499 for serving as a Consultant for Ceribell. Dr. Benbadis has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for SK Lifesciences. Dr. Benbadis has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Jazz. Dr. Benbadis has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Benbadis has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Neurelis. Dr. Benbadis has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Benbadis has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Livanova. Dr. Benbadis has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Benbadis has received research support from Greenwich/Jazz. The institution of Dr. Benbadis has received research support from SK Lifesciences.